PGTRX
Price
$72.34
Change
-$0.28 (-0.39%)
Updated
Dec 17 closing price
PRGTX
Price
$21.53
Change
-$0.06 (-0.28%)
Updated
Dec 17 closing price
Ad is loading...

PGTRX vs PRGTX

Header iconPGTRX vs PRGTX Comparison
Open Charts PGTRX vs PRGTXBanner chart's image
Putnam Global Technology R
Price$72.34
Change-$0.28 (-0.39%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Global Technology
Price$21.53
Change-$0.06 (-0.28%)
VolumeN/A
CapitalizationN/A
PGTRX vs PRGTX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PGTRX vs. PRGTX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGTRX is a Hold and PRGTX is a StrongBuy.

FUNDAMENTALS
Fundamentals
PRGTX has more cash in the bank: 4.75B vs. PGTRX (1.39B). PGTRX pays higher dividends than PRGTX: PGTRX (0.22) vs PRGTX (0.00). PGTRX was incepted earlier than PRGTX: PGTRX (16 years) vs PRGTX (24 years). PGTRX is a more actively managed with annual turnover of: 57.00 vs. PRGTX (53.90). PGTRX has a lower initial minimum investment than PRGTX: PGTRX (0) vs PRGTX (2500). PRGTX annual gain was more profitable for investors over the last year : 38.01 vs. PGTRX (31.82). PGTRX return over 5 years is better than : 77.49 vs. PRGTX (31.92).
PGTRXPRGTXPGTRX / PRGTX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years24 years-
Gain YTD30.88537.39683%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.39B4.75B29%
Annual Yield % from dividends0.220.00-
Returns for 1 year31.8238.0184%
Returns for 3 years12.53-5.07-247%
Returns for 5 years77.4931.92243%
Returns for 10 years232.6974.61312%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PK15.490.09
+0.58%
Park Hotels & Resorts
FE39.84-0.06
-0.15%
FirstEnergy Corp
JYD1.78N/A
-0.28%
Jayud Global Logistics Limited
DMAC5.20-0.11
-2.07%
DiaMedica Therapeutics
ADPT6.52-0.26
-3.83%
Adaptive Biotechnologies Corp